335 related articles for article (PubMed ID: 24496511)
1. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral.
Rush T; Buisson A
Cell Tissue Res; 2014 May; 356(2):279-86. PubMed ID: 24496511
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
[TBL] [Abstract][Full Text] [Related]
4. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.
Bordji K; Becerril-Ortega J; Buisson A
Rev Neurosci; 2011; 22(3):285-94. PubMed ID: 21568789
[TBL] [Abstract][Full Text] [Related]
5. Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.
Bordji K; Becerril-Ortega J; Nicole O; Buisson A
J Neurosci; 2010 Nov; 30(47):15927-42. PubMed ID: 21106831
[TBL] [Abstract][Full Text] [Related]
6. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
Vizi ES; Kisfali M; Lőrincz T
Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
[TBL] [Abstract][Full Text] [Related]
7. Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-β peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors.
Kervern M; Angeli A; Nicole O; Léveillé F; Parent B; Villette V; Buisson A; Dutar P
J Alzheimers Dis; 2012; 32(1):183-96. PubMed ID: 22785392
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β.
Wang ZC; Zhao J; Li S
Neurosci Bull; 2013 Dec; 29(6):752-60. PubMed ID: 24136243
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers.
Costa RO; Lacor PN; Ferreira IL; Resende R; Auberson YP; Klein WL; Oliveira CR; Rego AC; Pereira CM
Aging Cell; 2012 Oct; 11(5):823-33. PubMed ID: 22708890
[TBL] [Abstract][Full Text] [Related]
10. Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss.
Birnbaum JH; Bali J; Rajendran L; Nitsch RM; Tackenberg C
Cell Death Dis; 2015 Jun; 6(6):e1791. PubMed ID: 26086964
[TBL] [Abstract][Full Text] [Related]
11. Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
Ferreira IL; Ferreiro E; Schmidt J; Cardoso JM; Pereira CM; Carvalho AL; Oliveira CR; Rego AC
Neurobiol Aging; 2015 Feb; 36(2):680-92. PubMed ID: 25442114
[TBL] [Abstract][Full Text] [Related]
12. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.
Huang Y; Shen W; Su J; Cheng B; Li D; Liu G; Zhou WX; Zhang YX
J Alzheimers Dis; 2017; 57(3):885-897. PubMed ID: 28269783
[TBL] [Abstract][Full Text] [Related]
13. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.
Tu S; Okamoto S; Lipton SA; Xu H
Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486
[TBL] [Abstract][Full Text] [Related]
14. Memantine reduces the production of amyloid-β peptides through modulation of amyloid precursor protein trafficking.
Ito K; Tatebe T; Suzuki K; Hirayama T; Hayakawa M; Kubo H; Tomita T; Makino M
Eur J Pharmacol; 2017 Mar; 798():16-25. PubMed ID: 28167259
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
17. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors.
Léveillé F; El Gaamouch F; Gouix E; Lecocq M; Lobner D; Nicole O; Buisson A
FASEB J; 2008 Dec; 22(12):4258-71. PubMed ID: 18711223
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer's disease, amyloid peptide and synaptic dysfunction].
Hémar A; Mulle C
Med Sci (Paris); 2011; 27(8-9):733-6. PubMed ID: 21880261
[TBL] [Abstract][Full Text] [Related]
19. GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo.
Hu NW; Klyubin I; Anwyl R; Rowan MJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20504-9. PubMed ID: 19918059
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-β142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
Song Y; Du Z; Chen X; Zhang W; Zhang G; Li H; Chang L; Wu Y
J Alzheimers Dis; 2022; 85(1):167-178. PubMed ID: 34776441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
